Have you read these stories?

Johnson & Johnson starts phase 3 vaccine trial

US drugmaker Johnson & Johnson says the vaccine could be available for use by early 2021 if proven safe, effective. In the next phase ...
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 24 September, 2020, 05:02 AM IST | E-Paper
Search
+

    SEARCHED FOR:GLOBAL HEADWINDS

    Indian market in sweet spot, but could correct if global headwinds persist: Experts

    There is no doubt that India is in a sweet spot, but analysts advise investors to proceed with caution and remain stock-specific.

    FPIs pull out over Rs 6,200 crore in October so far

    Foreign investors pulled out a net amount of Rs 4,955.2 crore from the equities.

    Global brokerages cut target prices on Eicher Motors after Q1 results

    CLSA cut the target price of Eicher Motors to Rs 19,000 from Rs 21,000 ...

    Load More...
    x
    The Economic Times